Literature DB >> 17069939

Scientific lessons from the first influenza pandemic of the 20th century.

J S Oxford1, R Lambkin, A Elliot, R Daniels, A Sefton, D Gill.   

Abstract

Re-analysis of the influenza pandemic of 1918 has given reassurance about a rather low reproductive number (R(o)), a prolonged herald wave of virus and that the skewed mortality towards the young adult could be a singularly unique event dependent upon previous infection history, perhaps not to be repeated in a future pandemic. Over 99% of those who contracted the virus survived, in spite of the absence of antivirals, vaccine and antibiotics for the secondary bacteria infections which probably accounted for one-third of the 50 million deaths. Therefore, in spite of a three-fold population increase since 1918 and 100 thousand plane journeys daily, judicious and careful planning together with a stockpile of antiviral drugs, oseltamivir, zanamivir and M2 blockers and a generic H5N1 vaccine, and application of hygiene would be expected to reduce mortality in a new pandemic, to figures significantly less than 1918.

Entities:  

Mesh:

Year:  2006        PMID: 17069939     DOI: 10.1016/j.vaccine.2006.05.101

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.

Authors:  Peter Pushko; Irina Tretyakova; Rachmat Hidajat; Xiangjie Sun; Jessica A Belser; Terrence M Tumpey
Journal:  Vaccine       Date:  2018-06-07       Impact factor: 3.641

2.  Encephalitis lethargica and the influenza virus. II. The influenza pandemic of 1918/19 and encephalitis lethargica: epidemiology and symptoms.

Authors:  Paul Bernard Foley
Journal:  J Neural Transm (Vienna)       Date:  2009-08-26       Impact factor: 3.575

Review 3.  Pandemic influenza: certain uncertainties.

Authors:  David M Morens; Jeffery K Taubenberger
Journal:  Rev Med Virol       Date:  2011-06-27       Impact factor: 6.989

4.  Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.

Authors:  Darrell R Kapczynski; Terrence M Tumpey; Rachmat Hidajat; Aniko Zsak; Klaudia Chrzastek; Irina Tretyakova; Peter Pushko
Journal:  Vaccine       Date:  2016-02-08       Impact factor: 3.641

5.  Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.

Authors:  Peter Pushko; Xiangjie Sun; Irina Tretyakova; Rachmat Hidajat; Joanna A Pulit-Penaloza; Jessica A Belser; Taronna R Maines; Terrence M Tumpey
Journal:  Vaccine       Date:  2016-09-20       Impact factor: 3.641

Review 6.  Port d'Entrée for Respiratory Infections - Does the Influenza A Virus Pave the Way for Bacteria?

Authors:  Nikolai Siemens; Sonja Oehmcke-Hecht; Thomas C Mettenleiter; Bernd Kreikemeyer; Peter Valentin-Weigand; Sven Hammerschmidt
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

Review 7.  The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics.

Authors:  Rob Lambkin-Williams; Nicolas Noulin; Alex Mann; Andrew Catchpole; Anthony S Gilbert
Journal:  Respir Res       Date:  2018-06-22

8.  Deaths from bacterial pneumonia during 1918-19 influenza pandemic.

Authors:  John F Brundage; G Dennis Shanks
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

9.  Pandemic influenza forecasting: does past performance indicate future performance?

Authors:  Julian W Tang
Journal:  Am J Infect Control       Date:  2008-09       Impact factor: 2.918

Review 10.  [Emerging viral infectious diseases and pregnancy].

Authors:  P-F Ceccaldi; P Longuet; L Mandelbrot
Journal:  Gynecol Obstet Fertil       Date:  2007-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.